Recent News

• 04.22.2025 - Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
• 04.22.2025 - Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
• 04.22.2025 - Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
• 04.22.2025 - Akari Therapeutics Releases Welcome Video from Newly Appointed Chief Executive Officer, Abizer Gaslightwala
• 04.22.2025 - Welcome from Abizer Gaslightwala, President and CEO
• 04.16.2025 - Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
• 04.16.2025 - Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
• 04.16.2025 - Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update

Recent Filings

• 04.16.2025 - EX-99.1 EX-99.1
• 04.16.2025 - 8-K Current report
• 04.15.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.31.2025 - NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
• 03.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 4 Statement of changes in beneficial ownership of securities